Studies of RET gene expression and acetylcholinesterase activity in a series of sporadic Hirschsprung’s disease

2008 ◽  
Vol 24 (9) ◽  
pp. 1017-1021 ◽  
Author(s):  
Maria Cecília M. Coelho ◽  
Uenis Tannuri ◽  
Israel Benditt ◽  
Maria Merces Santos
1972 ◽  
Vol 7 (1) ◽  
pp. 11-17 ◽  
Author(s):  
W. Meier-Ruge ◽  
P.M. Lutterbeck ◽  
B. Herzog ◽  
R. Morger ◽  
R. Moser ◽  
...  

2019 ◽  
Vol 11 (1) ◽  
Author(s):  
Emilie G. Jaroy ◽  
Lourdes Acosta-Jimenez ◽  
Ryo Hotta ◽  
Allan M. Goldstein ◽  
Ragnhild Emblem ◽  
...  

Abstract Hirschsprung disease is a neurocristopathy, characterized by aganglionosis in the distal bowel. It is caused by failure of the enteric nervous system progenitors to migrate, proliferate, and differentiate in the gut. Development of an enteric nervous system is a tightly regulated process. Both the neural crest cells and the surrounding environment are regulated by different genes, signaling pathways, and morphogens. For this process to be successful, the timing of gene expression is crucial. Hence, alterations in expression of genes specific for the enteric nervous system may contribute to the pathogenesis of Hirschsprung’s disease. Several epigenetic mechanisms contribute to regulate gene expression, such as modifications of DNA and RNA, histone modifications, and microRNAs. Here, we review the current knowledge of epigenetic and epitranscriptomic regulation in the development of the enteric nervous system and its potential significance for the pathogenesis of Hirschsprung’s disease. We also discuss possible future therapies and how targeting epigenetic and epitranscriptomic mechanisms may open new avenues for novel treatment.


2019 ◽  
Vol 30 (01) ◽  
pp. 059-063 ◽  
Author(s):  
Anne Marie O'Donnell ◽  
Hiroki Nakamura ◽  
Prem Puri

Abstract Introduction “Tuft” cells, also known as brush or caveolated cells, are characteristically fusiform shaped, with a distinct apical “tuft” of microvilli extending into the lumen. Double cortin-like kinase 1 (DCLK1) is a microtubule kinase and is a specific marker of intestinal tuft cells. DCLK1-positive tuft cells have been shown to play a key role in gastrointestinal chemosensation, inflammation, and neurotransmission. DCLK1 and Choline acetyltransferase (ChAT), the enzymes responsible for acetylcholine production, are reported to be coexpressed within the gastrointestinal tract. We designed this study to investigate the hypothesis that DCLK1 gene expression is altered in Hirschsprung's disease (HSCR). Materials and Methods HSCR tissue specimens (n = 6) were collected at the time of pull-through surgery, while control samples were obtained at the time of colostomy closure in patients with imperforate anus (n = 6). Quantitative real-time polymerase chain reaction (qRT-PCR) analysis was undertaken to quantify DCLK1 gene expression, and immunolabeling of DCLK1-positive tuft cells was visualized using confocal microscopy. Results qRT-PCR analysis revealed significant downregulation of the DCLK1 gene in both aganglionic and ganglionic HSCR specimens compared with controls (p < 0.05). Confocal microscopy revealed DCLK1-positive tuft cell expression within the colonic mucosa, with a reduction in expression in both aganglionic and ganglionic HSCR colon compared with controls. Conclusion DCLK1 is significantly downregulated in HSCR colon, suggesting a role for tuft cells in cholinergic neurotransmission of the distal colon. The marked decrease in DCLK1 expression within ganglionic specimens highlights the physiologically abnormal nature of this segment in HSCR patients.


1991 ◽  
Vol 26 (2) ◽  
pp. 190-191 ◽  
Author(s):  
O. Atias ◽  
R. Finaly ◽  
N. Meyerstein ◽  
A.J. Mares

2012 ◽  
Vol 172 (2) ◽  
pp. 197
Author(s):  
A.C. Pieretti ◽  
C.E. Steiger ◽  
A.M. Goldstein

Sign in / Sign up

Export Citation Format

Share Document